Request for Interest (RFI)
BIO Ventures for Global Health (BVGH) invites investigators to submit information regarding their interests in conducting cancer clinical trials (feasibility studies) in sub-Saharan Africa (herein referred to as “Africa”). The studies described must (1) be conducted in Africa by an Africa-based investigator or with an Africa-based partner, (2) focus on one or more of the most common cancers in African populations, and (3) be aimed at improving African cancer patients’ health outcomes.

Responses to this RFI may be shared, wholly or in part, with potential funders of BVGH's clinical trial study pool (AC3T Study Pool). Please do not include any confidential or proprietary information in your submission.

Please complete and submit one form for each cancer feasibility study you are interested in performing in Africa.

For more information about BVGH and the AC3T Study Pool, please email Katy Graef (kgraef@bvgh.org).

Section 1: Respondent Information
Respondent Last (Family) Name *
Your answer
Respondent First (Given) Name (s) *
Your answer
Respondent Title(s) (e.g., Professor of Medicine) *
Your answer
Respondent Email Address *
Your answer
Respondent Phone Number (with country code)
Your answer
Respondent Organization Name *
Your answer
Address *
Your answer
City *
Your answer
Province, State, or Territory (if applicable)
Your answer
Postal Code (if applicable)
Your answer
Country *
Your answer
Relevant Prior Experience Conducting Cancer Clinical Trials *
(1500 characters maximum)
Your answer
Section 2: Cancer Clinical Trial Information
Clinical trials are defined as clinical research that evaluates and tests therapies, medications, and/or devices. Cancer feasibility studies are defined as investigator-initiated clinical trials using current standards of care (FDA approved drugs), a primary goal of which is to demonstrate that a site can conduct a cancer clinical trial. Social, behavioral, and early-stage genomic studies are not consistent with the intent of this RFI.
Study Title *
Your answer
Cancer Indication(s) *
Check all that apply. Please note that for the purposes of this RFI, studies focused on high-prevalence cancers are strongly preferred.
Required
Other
Your answer
Estimated Study Budget *
Inclusive of direct and indirect costs, in US dollars
Your answer
Does the Study Budget Include Funding to Procure the Study Medication(s) or Intervention(s)? *
If "No," How Will the Study Intervention(s) be Obtained/Paid For?
(1500 characters maximum)
Your answer
What Percentage of the Study Budget Would You Anticipate Requesting from the AC3T Study Pool? *
(0-100%)
Your answer
If the percentage is greater than 0 but less than 100, list other anticipated funding sources and the estimated percent contribution of each to the total study budget
(1500 characters maximum)
Your answer
Estimated Study Duration *
(In months)
Your answer
Study Background *
(1500 characters maximum)
Your answer
Study Objectives *
(1500 characters maximum)
Your answer
How is the Study Anticipated to Improve Cancer Patient Outcomes in Africa? *
(1500 characters maximum)
Your answer
Study Design *
(including arms and interventions, data acquisition and analysis methods, endpoint measurements, and planned correlatives as relevant) (1500 characters max)
Your answer
Do You Plan to Bank Study Specimens for Future Investigations? *
If "Yes," Please Describe Relevant Experience Managing Biobanks
(1500 characters maximum)
Your answer
Study Location(s) (country name[s]) *
Your answer
Study Location(s) (additional details, as available [e.g., hospitals, cities])
(1500 characters maximum)
Your answer
Study Population(s) (check all that apply) *
Required
Other Co-Morbidity
Your answer
Study Eligibility Criteria *
(1500 characters maximum)
Your answer
Anticipated Number of Patients (total across all study arms) *
Your answer
Key Partners (individuals and/or organizations, as applicable)
(1500 characters maximum)
Your answer
Primary Outcome Measures *
(1500 characters maximum)
Your answer
Secondary Outcome Measures (if applicable)
(1500 characters maximum)
Your answer
Expected Next Steps if Study is Successful *
(1500 characters maximum)
Your answer
Submit
Never submit passwords through Google Forms.
This content is neither created nor endorsed by Google. Report Abuse - Terms of Service - Additional Terms